[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100258789":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":26,"responsibleParty":44,"collaborators":46,"id":49,"slug":10,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":57,"maxAge":10,"enrollmentInfo":58,"targetDuration":10,"studyType":61,"phases":10,"briefSummary":62,"conditions":63,"keywords":10,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Landspitali University Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Hepatitis C infected",null,"All patients diagnosed with hepatitis C in Iceland",[13],{"name":14,"affiliation":5,"role":15},"Sigurdur Olafsson, MD","PRINCIPAL_INVESTIGATOR",[17,22],{"name":18,"role":19,"phone":20,"phoneExt":10,"email":21},"Ragnheidur Fridriksdottir, B.Sc, MA","CONTACT","+ 354 543 6096","ragnhefr@landspitali.is",{"name":23,"role":19,"phone":24,"phoneExt":10,"email":25},"Halla Arnardottir, B Sc","+354 5435711","hallarn@landspitali.is",[27],{"facility":28,"status":29,"city":30,"state":10,"zip":10,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Landspitali","RECRUITING","Reykjavik","Iceland","IS",{"type":34,"coordinates":35},"Point",[36,37],-21.89541,64.13548,{"lat":37,"lon":36},[40,42],{"name":41,"role":19,"phone":10,"phoneExt":10,"email":10},"Ragnheidur Fridriksdottir",{"name":43,"role":19,"phone":10,"phoneExt":10,"email":10},"Halla Arnardottir",{"type":45,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[47],{"name":48,"class":6},"National Center of Addiction Medicine (SAA)","100258789",false,"NCT02647879","Treatment as Prevention for Hepatitis C in Iceland","Treatment as Prevention for Hepatitis C in Iceland. A Nationwide Campaign for Reducing Disease Burden Using Combination Antiviral Treatment","TraPHepC","Inclusion Criteria:\n\n* HCV positive subjects 18 years and older, living in Iceland and covered by the Icelandic Health Insurance.\n\nExclusion Criteria:\n\n* Age under 18 years\n* Inability to sign informed consent.","ALL","18 Years",{"count":59,"type":60},1000,"ESTIMATED","OBSERVATIONAL","The main aim of this study is to test in the Icelandic population the hypothesis that a nationwide treatment program which offers effective treatment to all known cases of Hepatitis C with the aim of halting HCV (Hepatitis C virus) transmission will lead to a reduction in incidence and disease burden associated with chronic HCV infection.",[64],"Hepatitis C","2020-09-24",{"date":67,"type":68},"2020-09-25","ACTUAL",{"date":70,"type":10},"2016-01",{"date":72,"type":60},"2031-05",{"name":5,"class":6},1]